These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2179491)

  • 21. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zidovudine for chemoprophylaxis after occupational exposure to HIV-infected blood: an economic evaluation.
    Allen UD; Read S; Gafni A
    Clin Infect Dis; 1992 Apr; 14(4):822-30. PubMed ID: 1576276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Needlestick injuries and the risk of HIV infections.
    Calif Nurse; 1989 Mar; 85(3):4. PubMed ID: 2702518
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Rooney J; Meng TC; Fischl MA; Collier AC; Phair JP; Hirsch MS
    N Engl J Med; 1995 Aug; 333(7):401-7. PubMed ID: 7616988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy.
    Lancet; 1993 Apr; 341(8852):1077-8. PubMed ID: 8096971
    [No Abstract]   [Full Text] [Related]  

  • 26. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should you take zidovudine after a needle stick?
    Gingrich MM
    Nursing; 1990 Sep; 20(9):18, 19. PubMed ID: 2395548
    [No Abstract]   [Full Text] [Related]  

  • 28. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
    MMWR Recomm Rep; 1990 Jan; 39(RR-1):1-14. PubMed ID: 2105451
    [No Abstract]   [Full Text] [Related]  

  • 29. Zidovudine: a review of pharmacoeconomic and quality-of-life considerations for its use in patients with human immunodeficiency virus.
    Langtry HD; Palmer KJ; Benfield P
    Pharmacoeconomics; 1993 Apr; 3(4):309-37. PubMed ID: 10146993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational exposure to HIV and zidovudine chemoprophylaxis.
    Smart NG
    Anaesthesia; 1990 Nov; 45(11):989-90. PubMed ID: 2252205
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV transmission! Potential risks for providers.
    Pazin GJ
    Pa Med; 1990 Feb; 93(2):58-60. PubMed ID: 2314912
    [No Abstract]   [Full Text] [Related]  

  • 32. Zidovudine (Retrovir) update.
    Rachlis AR
    CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
    N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Needlestick injuries, surgeons, and HIV risks.
    Leentvaar-Kuijpers A; Dekker MM; Coutinho RA; Dekker EE; Keeman JN; Ansink-Schipper MC
    Lancet; 1990 Mar; 335(8688):546-7. PubMed ID: 1968560
    [No Abstract]   [Full Text] [Related]  

  • 35. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.
    Vella S; Giuliano M; Pezzotti P; Agresti MG; Tomino C; Floridia M; Greco D; Moroni M; Visco G; Milazzo F
    JAMA; 1992 Mar; 267(9):1232-6. PubMed ID: 1538560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal precautions to prevent HIV transmission to health care workers: an economic analysis.
    Stock SR; Gafni A; Bloch RF
    CMAJ; 1990 May; 142(9):937-46. PubMed ID: 2158390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zidovudine after occupational exposure to HIV.
    Jeffries DJ
    BMJ; 1991 Jun; 302(6789):1349-51. PubMed ID: 2059707
    [No Abstract]   [Full Text] [Related]  

  • 38. Study to test post HIV exposure in health care employees.
    Dent Manage; 1988 Aug; 28(8):17. PubMed ID: 3058533
    [No Abstract]   [Full Text] [Related]  

  • 39. Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. The Italian Study Group on Occupational Risk of HIV Infection.
    Puro V; Ippolito G; Guzzanti E; Serafin I; Pagano G; Suter F; Cristini G; Arici C; Angarano G; Soscia F
    AIDS; 1992 Sep; 6(9):963-9. PubMed ID: 1388909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zidovudine after occupational exposure to HIV.
    BMJ; 1991 Jul; 303(6794):118-9. PubMed ID: 1859988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.